Peter Goldschmidt

Peter Goldschmidt is the Chief Executive Officer at STADA Group, a global healthcare company focusing on Generics, Specialty Pharma, and Consumer Healthcare products.

With a career spanning over three decades in the healthcare industry, Peter has held various leadership positions at Novartis and Sandoz across Europe, Asia, and the US, specializing in OTC, Generics, and innovative Pharma.

Peter Goldschmidt served as the President of Sandoz US and Head of North America from 2013 to 2018, contributing to the growth and success of the organization during his tenure.

Driven by a passion for building sustainable growth businesses, Peter emphasizes the importance of diverse teams and a purpose-driven culture for fostering success and overcoming challenges.

Peter Goldschmidt's educational background includes studies at prestigious institutions such as the University of Münster, Harvard Business School, London Business School, and Stanford University Graduate School of Business.

He is committed to STADA's purpose of 'Caring for People's Health as a Trusted Partner,' focusing on global growth, a competitive product portfolio, and strategic partnerships.

Throughout his career, Peter has demonstrated a dedication to helping individuals protect and improve their quality of life through innovative healthcare solutions.

Peter Goldschmidt's professional journey includes leadership roles in Germany, Sweden, Philippines, Singapore, Indonesia, and various regions, showcasing his global perspective and adaptability in diverse markets.